This program includes material from an approved satellite symposium of the American Society of Nephrology 33rd Annual Scientific Meeting, October, 2000

This program is sponsored by the Excerpta Medica Office of Continuing Medical Education. This is an approved ASN satellite symposium. It is not part of the official 33rd Annual Meeting as planned by the ASN Program Committee. Supported by an unrestricted educational grant from Ortho Biotech, Inc.

To access this self study program at no charge please click here to register first with HDCN. This program offers 2.0 hours of Category One CME Credit for Physicians through Excerpta Medica Office of Continuing Medical Education.

CME-related forms
Evaluation Form	Post-Test

---

Activity Rationale

This activity is designed to provide the latest information on anemia associated with renal insufficiency, its pathophysiology, and its effects on the cardiovascular system. Also included are the impact of renal anemia and the comorbid conditions hypertension, diabetes, and the dyslipidemias; how they work together in the progression of renal disease; and appropriate interventions. A key part of the program is the approach to the management of early renal anemia, including diagnosis and the initiations of erythropoietin therapy and other agents as necessary. The need for early referral to a specialist is emphasized, as are the consequences of late referral.

Upon completion of this activity, the participant should be able to:

1. Discuss the prevalence of early renal insufficiency (ERI) and the factors involved in its increase;
2. Discuss the association between ERI and anemia and the population at risk for developing renal anemia;
3. Outline the potential complications associated with ERI, including some of the deleterious effects of anemia such as impaired cardiac function, diminished exercise capacity, and reduced quality of life;
4. Examine current data and relate it to quality of life issues during treatment of the ERI patient;
5. Explain the current barriers to ERI management;
6. Describe a multidisciplinary team approach to identifying, educating, and treating patients with ERI;
7. Describe appropriate outcome measures for ERI monitoring; and
8. Discuss the goals of ERI management and describe what components are needed for optimal ERI care.
   

	Renal Insufficiency Intervention: Trends in Anemia in the United States Allan J. Collins, M.D.
	Epidemiology of Anemia in ERI: What We Know and What We Need to Know William M. McClellan, M.D., M.P.H.
	Systemically Administered rHu-EPO Protects and Improves Brain Function Carla Cerami, MD, PhD
	The Burden of Cardiovascular Disease in Renal Disease: Risk Factor Intervention in Chronic Renal Insufficiency Patrick S. Parfrey, MD
	Frontiers in Nephrology Practice: Components Shaping the Successful ERI Clinic William F. Owen, Jr, MD
	Questions and Answers Drs. Collins, McClellan, Parfrey, and Owen

Allan J. Collins, MD, Professor of Medicine, Hennepin County Medical Center, University of Minnesota School of Medicine, Minneapolis, MN. Director, Nephrology Analytical Services, Minneapolis Medical Research Foundation.

William M. McClellan, MD, MPH. Clinical Professor of Medicine, Emory University, Atlanta, GA. Medical Director, Health Services Research, Georgia Medical Care Foundation.

Carla Cerami, MD, PhD, Vice-President, Cerami Consulting Group, Tarrytown, NY.

Patrick S. Parfrey, MD, University Research Professor and Chief, Epidemiology Unit, Memorial University, St. John's, Newfoundland, Canada.